H.R. 5509: Safe Step Act

The Safe Step Act targets a common insurance practice known as step therapy, sometimes called “fail first.” Under that approach, a patient may have to try one or more insurer-preferred drugs before the plan will cover the drug chosen by the patient’s doctor. Supporters say step therapy can delay effective treatment, especially for people with chronic or complex conditions. This bill does not ban step therapy, but it would make plans subject to ERISA create a formal exceptions process and honor exceptions when certain medical conditions are met.

The core idea is simple: if the required drug has already failed, is likely to fail, could cause harm, or would put the patient at serious risk by delaying proper treatment, the plan must have a way to approve the doctor’s original prescription. The bill also protects patients who are already stable on a medication and have previously had it covered by another public or private health plan. That continuity-of-care piece is especially important for people who change jobs or insurers and suddenly face new coverage barriers.

The bill also tries to make the process usable in real life. Plans would have to use a clear standard form, accept requests on paper and electronically, limit paperwork to what is strictly necessary, and tell patients and doctors exactly what information is needed. A representative, including a third-party advocate, could act for the patient. In short, it aims to reduce the paperwork maze that often frustrates patients and providers.

The practical impact could be significant for employer-sponsored coverage, because ERISA governs many workplace health plans. Insurers and plan administrators would face tighter deadlines, including 72 hours for standard requests and as fast as 24 hours in urgent cases. The main unresolved question is scope: the text provided focuses on ERISA-regulated group health plans, so its reach would be strongest in employer coverage rather than every type of insurance market. If enacted, the bill would likely shift some decision-making power back toward doctors and patients, while increasing compliance and administrative obligations for plans.